# Bristol Myers Squibb

Type: Company

Source: Legal & RegTech Intelligence Brief — https://getlegalbrief.com/entity/bristol-myers-squibb
Canonical HTML page: https://getlegalbrief.com/entity/bristol-myers-squibb

## Recent coverage (1 stories)

### £300bn AstraZeneca-BMS Merger Faces Antitrust Firestorm Under Trump
2026-08-03 09:57:14 · Sentiment: Neutral · Impact: 9/10 · Sources: 4

The proposed mega-merger would immediately trigger intense antitrust reviews in the US, EU, and UK, testing the limits of Trump-era competition enforcement in the pharmaceutical sector. Significant divestitures and political pushback are likely, with a real risk of deal collapse.
Full story: https://getlegalbrief.com/story/astrazeneca-bms-merger-antitrust-300bn

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getlegalbrief.com/guides/methodology for the full editorial methodology.